Substrates for peptidase M06.001: immune inhibitor A peptidase (Bacillus sp.)

Summary Alignment Tree Sequences Sequence features Distribution Literature Substrates

Peptide and protein substrates that are thought to be physiologically relevant are indicated by P. Peptide and protein substrates that are thought to be pathologically relevant are indicated by D. Peptide and protein substrates that are not physiologically relevant are indicated by N. Synthetic substrates are indicated by S. Click on the symbol to show only physiological, non-physiological or synthetic substrates, or here to display all substrates. How cleavage sites have been identified are indicated by the following evidence codes: NT = N-terminal sequencing, MS = mass spectroscopy, MU = mutation, CS = consensus sequence, LC = liquid chromatography. To see all annotated cleavages for a protein substrate, click on the UniProt Accession.

Substrate	Uniprot	Residue range	Cleavage Site	Cleavage type	Evidence	P4	P3	P2	P1	P1'	P2'	P3'	P4'	Reference	CutDB
bacillolysin	P05806	28-566	peptide-Asp242+Ala-peptide	P	NT	Pro	Lys	Gln	Asp	Ala	Lys	Ala	Val	Haydar et al., 2018
bacillolysin	P05806	28-566	peptide-Ala245+Val-peptide	P	NT	Asp	Ala	Lys	Ala	Val	Val	Lys	Pro	Haydar et al., 2018
cecropin A (1-33)			Lys-Trp-Lys-Leu4+Phe-peptide	N		Lys	Trp	Lys	Leu	Phe	Lys	Lys	Ile	Woessner, 2004
cecropin A (1-33)			peptide-Lys7+Ile-peptide	N		Leu	Phe	Lys	Lys	Ile	Glu	Lys	Cys	Woessner, 2004
cecropin A (1-33)			peptide-Lys10+Cys-peptide	N		Lys	Ile	Glu	Lys	Cys	Gly	Gln	Asn	Woessner, 2004
cecropin A (1-33)			peptide-Gly12+Gln-peptide	N		Glu	Lys	Cys	Gly	Gln	Asn	Ile	Arg	Woessner, 2004
cecropin A (1-33)			peptide-Gln13+Asn-peptide	N		Lys	Cys	Gly	Gln	Asn	Ile	Arg	Asp	Woessner, 2004
cecropin A (1-33)			peptide-Asn13+Ile-peptide	N		Cys	Gly	Gln	Asn	Ile	Arg	Asp	Gly	Woessner, 2004
cecropin A (1-33)			peptide-Gly18+Ile-peptide	N		Ile	Arg	Asp	Gly	Ile	Ile	Lys	Ala	Woessner, 2004
cecropin A (1-33)			peptide-Ala22+Gly-peptide	N		Ile	Ile	Lys	Ala	Gly	Pro	Ala	Val	Woessner, 2004
cecropin A (1-33)			peptide-Ala27+Val-peptide	N		Ala	Gly	Pro	Ala	Val	Val	Gly	Gln	Woessner, 2004
cecropin A (1-33)			peptide-Val28+Val-peptide	N		Gly	Pro	Ala	Val	Val	Gly	Gln	Ala	Woessner, 2004
cecropin A (1-33)	P01507	27-59	peptide-Leu31+Phe-peptide	P		Lys	Trp	Lys	Leu	Phe	Lys	Lys	Ile	Dalhammar & Steiner, 1984	21677
cecropin A (1-33)	P01507	27-59	peptide-Lys34+Ile-peptide	P		Leu	Phe	Lys	Lys	Ile	Glu	Lys	Val	Dalhammar & Steiner, 1984	21678
cecropin A (1-33)	P01507	27-59	peptide-Gln40+Asn-peptide	P		Lys	Val	Gly	Gln	Asn	Ile	Arg	Asp	Dalhammar & Steiner, 1984	21681
cecropin A (1-33)	P01507	27-59	peptide-Lys36+Val-peptide	P		Lys	Ile	Glu	Lys	Val	Gly	Gln	Asn	Dalhammar & Steiner, 1984	21682
cecropin A (1-33)	P01507	27-59	peptide-Asn41+Ile-peptide	P		Val	Gly	Gln	Asn	Ile	Arg	Asp	Gly	Dalhammar & Steiner, 1984	21683
cecropin A (1-33)	P01507	27-59	peptide-Gly45+Ile-peptide	P		Ile	Arg	Asp	Gly	Ile	Ile	Lys	Ala	Dalhammar & Steiner, 1984	21684
cecropin A (1-33)	P01507	27-59	peptide-Ala49+Gly-peptide	P		Ile	Ile	Lys	Ala	Gly	Pro	Ala	Val	Dalhammar & Steiner, 1984	21685
cecropin A (1-33)	P01507	27-59	peptide-Val55+Val-peptide	P		Ala	Val	Ala	Val	Val	Gly	Gln	Ala	Dalhammar & Steiner, 1984	21686
cecropin A (1-33)	P01507	27-59	peptide-Ala54+Val-peptide	P		Pro	Ala	Val	Ala	Val	Val	Gly	Gln	Dalhammar & Steiner, 1984	21687
syndecan-1	P18828	23-311	peptide-Gly48+Thr-peptide	P		Ser	Gly	Ser	Gly	Thr	Gly	Ala	Leu	Chung et al., 2006	21090
von Willebrand factor	P04275	23-2813	peptide-Arg763+Ser-peptide	N		Arg	Ser	Lys	Arg	Ser	Leu	Ser	Cys	Chung et al., 2008	21086
von Willebrand factor	P04275	23-2813	peptide-Leu1664+Val-peptide	N		Ala	Pro	Asp	Leu	Val	Leu	Gln	Arg	Chung et al., 2008	21087